AHA: CMS proposal for drug ad transparency ‘important first step’

The AHA voiced support for a Centers for Medicare & Medicaid Services’ proposal to require drug pricing transparency in direct-to-consumer television advertisements and encouraged the agency to “rein in skyrocketing drug prices” for patients and the providers who serve them. “We appreciate CMS’s focus on this issue, and we believe this proposal represents an important first step in bringing more transparency to drug pricing,”

Related Resources

Infographics
Public
Guides/Reports
Public
The American Hospital Association (AHA), the Federation of American Hospitals (FAH), and the American Society of Health-System Pharmacists (ASHP) released a…
Member
Letter
Public
AHA letter to the US Senate supporting Amendment #3787 to address ‘out-of-control cost’ of prescription drugs.
Letter
Public
AHA comments on the 340B section of the Department of Health and Human Services’ Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs.
Letter
Public
AHA commends MedPAC and HHS for voicing significant concerns about rising pharmaceutical costs.